{"id":"W7092477290","doi":"10.51731/cjht.2025.1256","title":"Glofitamab (Columvi)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Oxaliplatin; Gemcitabine; Refractory (planetary science); Lymphoma; Drug; Chemotherapy; Diffuse large B-cell lymphoma","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001149389,0.001058198,0.001007946,0.001627642,0.001098269,0.00251171,0.001484554,0.002381242,0.197513],"category_scores_gemma":[0.001541748,0.000419301,0.0009246203,0.000776013,0.0007514091,0.001016687,0.001569252,0.003211857,0.1028205],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003045791,"about_ca_system_score_gemma":0.005330713,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01440465,"about_ca_topic_score_gemma":0.02463735,"domain_scores_codex":[0.9990244,0.00009711941,0.00003706044,0.0002027688,0.0003933276,0.0002453336],"domain_scores_gemma":[0.9991892,0.00005472014,0.00006438821,0.00006980641,0.0002189327,0.0004028775],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"systematic_review","study_design_scores_codex":[0.002681557,0.0005455194,0.002006236,0.0009263214,0.00008098867,0.0009232637,0.0001319659,0.0003713836,0.01482266,0.006312853,0.5134539,0.4577434],"study_design_scores_gemma":[0.0007851744,0.0004894473,0.001525755,0.0001706127,0.00003615371,0.0009799355,0.00003800717,0.0002006941,0.003068094,0.0006821759,0.9920066,0.00001738561],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"other","genre_gemma":"review","genre_scores_codex":[0.03270224,0.09925423,0.007311918,0.02725458,0.005984019,0.002711175,0.03129841,0.01437409,0.7791095],"genre_scores_gemma":[0.1424095,0.03687913,0.00878934,0.02549088,0.001031254,0.001242111,0.04617404,0.0016285,0.7363554],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.197513,"threshold_uncertainty_score":0.6607469,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0406180561604166,"score_gpt":0.3553585270236323,"score_spread":0.3147404708632157,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}